![[TXT]](/icons/text.gif) 121.1012-2010 ACCF.AHA Guideline for assessment of CV risk in ASx adults. Executive summary_Circulation.pdf | 634.79Kb | December 26 2010 |
| 121.1012-2010 ACCF.AHA Guideline for assessment of CV risk in ASx adults. Full text _Circulation.pdf | 947.16Kb | December 26 2010 |
| 135.1101-Effects of Obesity and subsequent weight reduction on LV function_Lakhani, Cardiol Rev.pdf | 93.56Kb | December 26 2010 |
| 139.1101-Erectile Dysfunction. A disease marker of CVD_Shin, Cardiol Rev.pdf | 842.84Kb | December 26 2010 |
| 224e.1101-Roles of anatomic factors, thrombophilia and antithrombotic therapies in childhood-onset aIS_Bernard, Thromb Res.pdf | 190.40Kb | December 26 2010 |
| 364.1101-Abdominal aneurysm in systemic LE. MA of 35 cases in literature_Kurata, CardioV Pathol.pdf | 163.17Kb | December 26 2010 |
| 376m.1101-Pre-op Statin use on MMPs & TIMPs vs wall stress in patients undergoing AAA repair. RCT_A. Rahman, Ann Vasc Surg.pdf | 274.29Kb | December 26 2010 |
| 377s.1101-Evaluating outcomes of endoleak. Discrepancies between CTA and US imaging after EVAR-Nagre, Ann Vasc Surg.pdf | 341.66Kb | December 26 2010 |
| 420.1101-CV morbi-mortality in patients with rheumatoid arthritis_Pieringer, QJM.pdf | 164.06Kb | December 26 2010 |
| 421H.1011-Limited value of temporal artery US for Dg of GCA. Analysis of 77 subjects_Maldini, J Rheumatol.pdf | 276.78Kb | December 26 2010 |
| 421H.1012-GCA. Epidemiology, Diagnosis and Management_Gonzales Gay, Curr Rheumatol Rep.pdf | 143.52Kb | December 26 2010 |
| 422.1012-Behcet's syndrome_Yazici, Cur Rheumatol Rep.pdf | 139.92Kb | December 26 2010 |
| 461.1101-MRI of the Axillary Arch Muscle. Prevalence, Anatomic relations and potential consequences_Huy, AJR.pdf | 771.54Kb | December 26 2010 |
| 620.1012-Improving pratices in US hospitals to prevent VTE. Lessons from ENDORSE_Anderson, Am J Med.pdf | 228.83Kb | December 26 2010 |
| 622ot.1012-Apixaban vs Enoxaparin for Thromboprophylaxis after THR. ADVANCE-3_Lassen, nejm.pdf | 624.15Kb | December 26 2010 |
| 623.1101-Incidence and Characteristics of VTE during pregnancy and postpartum period_O'Connor, Ann Vasc Surg.pdf | 240.26Kb | December 26 2010 |
| 624.1012-GCS reduce DVT in hospitalized patients. Cochrane Review_Vazquez, Ann Intern Med.pdf | 253.72Kb | December 26 2010 |
| 648.1012-Routine screening for silent PE is harmful and unnecessary. Letter_Sommers, Am J Med.pdf | 59.15Kb | December 26 2010 |
| 671.1012-Oral Rivaroxaban for Sx VTE. EINSTEIN_Einstein investigators, nejm.pdf | 737.77Kb | December 26 2010 |
| 671.1012-Therapeutic potential of oral F.Xa inhibitors_Hylek, nejm. Editorial.pdf | 352.98Kb | December 26 2010 |
| 674.1012-Modest response in translation to home management of DVT_Stein, Am J Med.pdf | 192.43Kb | December 26 2010 |
| 741.1012-Six month exercise training program to treat PTS. RCT_Kahn, CMAJ.pdf | 205.38Kb | December 26 2010 |
| 752.1012-Medical and Surgical therapy for advanced CVI_Word, Surg Clin NA.pdf | 139.85Kb | December 26 2010 |
| 752.1012-Wound healing primer_Goldberg, Surg Clin NA.pdf | 944.33Kb | December 26 2010 |
| 753.1012-Active wound coverings. Bioengineered skin and dermal substitutes_Limovà, Surg Clin NA.pdf | 713.31Kb | December 26 2010 |
| 754.1012-Wound Surgery_Caldwell, Surg Clin NA.pdf | 89.06Kb | December 26 2010 |
| 758.1012-Complex wounds and their management_Park, Surg Clin NA.pdf | 119.82Kb | December 26 2010 |
| 758.1101-Effect of PTA on wound healing in patients with mixed arterial and venous disease_Lantis, Ann Vasc Surg.pdf | 579.43Kb | December 26 2010 |
| 759.1012-Unusual causes of cutaneous ulceration_Panuncialman, Surg Clin NA.pdf | 1.55Mb | December 26 2010 |
| 766a.1101-Laser saphenous ablations in 1000 LL with long-term DUS FU_Spreafico, Ann Vasc Surg.pdf | 461.94Kb | December 26 2010 |
![[DIR]](/icons/back.gif){kind=icon}
Parent Directory